drugset / Trial / NCT06740201

A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective Surgery

NCT06740201

Phase 4 Recruiting 40 enrolled Haisco Pharmaceutical Group Co., Ltd.
RandomizedParallel-groupOpen-labelOther

Summary

This study is a multi-center (each center independently conducts the study according to the same research protocol), randomized, and open-label clinical study. The main objective is to verify and optimize the accuracy of the target-controlled infusion model of cipepofol.

Timeline

Start
2025-01-06
Primary completion
2025-03-30
Completion
2025-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule

Indications

No indication recorded.